Skip to content

Study to Evaluate the Physiological Effects on the Skin of 3 Food Supplements Versus Placebo in 40-60 Years Old Female Subjects

Randomized and Double-blind Study to Evaluate the Physiological Effects on the Skin of 3 Food Supplements Versus Placebo in 40-60 Years Old Female Subjects

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06254209
Enrollment
132
Registered
2024-02-12
Start date
2023-11-06
Completion date
2024-06-03
Last updated
2026-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers

Brief summary

The objective is to evaluate the effects on the skin of 3 foods supplements compared to placebo after daily intake for 3 months in female subjects presenting healthy skin. Skin parameters measured are: the firmness of the skin and other biomechanical skin properties (elasticity, tonicity, density), cellulitis visibility, radiance complexion, skin condition (microrelief, skin barrier function and moisturizing)

Detailed description

Study design: Monocentric, randomized, double blind, placebo controlled, 3 groups in parallel.

Interventions

DIETARY_SUPPLEMENTBotanicals extracts

Powder included in capsules for daily administration

DIETARY_SUPPLEMENTPlacebo

Maltodextrin included in capsules for daily administration

Sponsors

Nexira
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
40 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy * Phototype II to IV (Fitzpatrick) * Visual skin radiance score (face) ≤ 7 (0 to 9 points numeric scale) * Tactile skin firmness score (cheek) ≤ 7 (0 to 9 points numeric scale) * Visual cellulite score (thigh) ≥ 3 (0 to 9 points numeric scale)

Exclusion criteria

* Chronic pathology or systemic disorder * Subjects presenting imperfections on the test sites * Pregnant or who are planning to become pregnant * Medication or condition that may interfere with tested outcomes

Design outcomes

Primary

MeasureTime frameDescription
Firmness of the skinDay 0 (inclusion) and Day 84 (last visit)Cutometry measurements using Cutometer (cheekbone)

Secondary

MeasureTime frameDescription
Skin elasticity and tonicityDay 0 (inclusion) and Day 84 (last visit)Cutometry measurements using the Cutometer (cheekbone)
Skin densityDay 0 (inclusion) and Day 84 (last visit)Ultrasound imaging device (lower cheek)
Score of fine lines visibility on face, assessed by panelist (trained technician)Day 0 (inclusion) and Day 84 (last visit)10 points numeric scale: 0 (not visible) to 9 (highly visible)
Score of skin radiance of face, assessed by panelist (trained technician)Day 0 (inclusion) and Day 84 (last visit)10 points numeric scale: 0 (dull) to 9 (radiant)
Score of nourishing aspect (hydration and quality aspect) of face, assessed by panelist (trained technician)Day 0 (inclusion) and Day 84 (last visit)10 points numeric scale: 0 (malnourished) to 9 (nourished)
Score of skin firmness (tactile pinch of right cheek), assessed by panelist (trained technician)Day 0 (inclusion) and Day 84 (last visit)10 points numeric scale: 0 (sagging) to 9 (firm)
Score of skin softness (tactile perception of right cheek), assessed by panelist (trained technician)Day 0 (inclusion) and Day 84 (last visit)10 points numeric scale: 0 (rough) to 9 (soft)
Score of cellulite visibility (right thigh), assessed by panelist (trained technician)Day 0 (inclusion) and Day 84 (last visit)10 points numeric scale: 0 (not visible) to 9 (highly visible)
Dimpled skin - volume (mm3) of humps and dimplesDay 0 (inclusion) and Day 84 (last visit)Picture acquisition by fringe projection (on tight) and software integration
Dimpled skin - surface (mm2) of humps and dimplesDay 0 (inclusion) and Day 84 (last visit)Picture acquisition by fringe projection (on tight) and software integration
Skin luminosity - CIELAB (L*a*b)Day 0 (inclusion) and Day 84 (last visit)Standardized pictures acquisitions (face) and software integration
Skin color texture - Haralick parameter (contrast & entropy - no unit)Day 0 (inclusion) and Day 84 (last visit)Standardized pictures acquisitions (face) and software integration
Skin specular reflectance (spectral reflectance - no unit)Day 0 (inclusion) and Day 84 (last visit)Standardized pictures acquisitions (face) and software integration
Skin roughness (mean height - µm)Day 0 (inclusion) and Day 84 (last visit)Standardized 3D pictures acquisitions (cheek) and software integration
Skin barrier function (g/h/m²)Day 0 (inclusion) and Day 84 (last visit)Trans-epidermal water loss (forearm)
Skin moisture (%)Day 0 (inclusion) and Day 84 (last visit)Reflected electromagnetic probe (forearm)
Self perceived questionnaire (4 scales)Day 0 (inclusion), Day 42 (intermediate) and Day 84 (last visit)Questionnaire (Satisfied, Somewhat satisfied, Somewhat unsatisfied, Unsatisfied)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 2, 2026